Skip to main content
Andor Glaudemans
prof. dr.

I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.

Cushingoid facies on (18)F-FDG PET/CT
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Ronald W. J. van Rheenen, Andor W. J. M. Glaudemans, Sabine L. A. Plasschaert, Walter Noordzij, Riemer H. J. A. Slart
Additional diagnostic value of SPECT/CT to planar Iodine-123 labeled serum amyloid P component scintigraphy in a patient with pulmonary nodular amyloidosis
Published in: Amyloid: Journal of protein folding disorders
Residual estrogen receptor availability during fulvestrant 500 mg therapy in patients with metastatic breast cancer.
Myocardial metastases on 6-[18F]fluoro-L-DOPA PET/CT: A retrospective analysis of 116 serotonin producing neuroendocrine tumor patients
Reply to comment by Koranda: Tc-99m-HMPAO-labelled leucocytes in musculoskeletal infections-the choice of reference tissue for a semiquantitative analysis
Published in: European Journal of Nuclear Medicine and Molecular Imaging